The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Apomorphine Delivery Device Market Research Report 2024
Synopsis
Apomorphine is a non-selective dopamine agonist which activates both D2-like and, to a much lesser extent, D1-like receptors. It also acts as an antagonist of 5-HT2 and α-adrenergic receptors with high affinity. The compound is historically a morphine decomposition product made by boiling morphine with concentrated acid, hence the -morphine suffix. Apomorphine does not actually contain morphine or its skeleton, nor does it bind to opioid receptors.
The global Apomorphine Delivery Device market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Apomorphine Delivery Device is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Apomorphine Delivery Device is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Apomorphine Delivery Device include Supernus Pharmaceuticals, Britannia Pharmaceuticals STADA, Ever Pharma and Evolan Pharma AB (PharmSwed), etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Apomorphine Delivery Device, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Apomorphine Delivery Device.
Report Scope
The Apomorphine Delivery Device market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Apomorphine Delivery Device market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Apomorphine Delivery Device manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Supernus Pharmaceuticals
Britannia Pharmaceuticals STADA
Ever Pharma
Evolan Pharma AB (PharmSwed)
Segment by Type
Pen Injectors
Infusion Pumps
Segment by Application
Parkinson Disease
Erectile Dysfunction
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Apomorphine Delivery Device manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Apomorphine Delivery Device in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Apomorphine is a non-selective dopamine agonist which activates both D2-like and, to a much lesser extent, D1-like receptors. It also acts as an antagonist of 5-HT2 and α-adrenergic receptors with high affinity. The compound is historically a morphine decomposition product made by boiling morphine with concentrated acid, hence the -morphine suffix. Apomorphine does not actually contain morphine or its skeleton, nor does it bind to opioid receptors.
The global Apomorphine Delivery Device market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Apomorphine Delivery Device is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Apomorphine Delivery Device is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Apomorphine Delivery Device include Supernus Pharmaceuticals, Britannia Pharmaceuticals STADA, Ever Pharma and Evolan Pharma AB (PharmSwed), etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Apomorphine Delivery Device, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Apomorphine Delivery Device.
Report Scope
The Apomorphine Delivery Device market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Apomorphine Delivery Device market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Apomorphine Delivery Device manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Supernus Pharmaceuticals
Britannia Pharmaceuticals STADA
Ever Pharma
Evolan Pharma AB (PharmSwed)
Segment by Type
Pen Injectors
Infusion Pumps
Segment by Application
Parkinson Disease
Erectile Dysfunction
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Apomorphine Delivery Device manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Apomorphine Delivery Device in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Apomorphine Delivery Device Market Overview
1.1 Product Overview and Scope of Apomorphine Delivery Device
1.2 Apomorphine Delivery Device Segment by Type
1.2.1 Global Apomorphine Delivery Device Market Value Comparison by Type (2024-2030)
1.2.2 Pen Injectors
1.2.3 Infusion Pumps
1.3 Apomorphine Delivery Device Segment by Application
1.3.1 Global Apomorphine Delivery Device Market Value by Application: (2024-2030)
1.3.2 Parkinson Disease
1.3.3 Erectile Dysfunction
1.4 Global Apomorphine Delivery Device Market Size Estimates and Forecasts
1.4.1 Global Apomorphine Delivery Device Revenue 2019-2030
1.4.2 Global Apomorphine Delivery Device Sales 2019-2030
1.4.3 Global Apomorphine Delivery Device Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Apomorphine Delivery Device Market Competition by Manufacturers
2.1 Global Apomorphine Delivery Device Sales Market Share by Manufacturers (2019-2024)
2.2 Global Apomorphine Delivery Device Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Apomorphine Delivery Device Average Price by Manufacturers (2019-2024)
2.4 Global Apomorphine Delivery Device Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Apomorphine Delivery Device, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Apomorphine Delivery Device, Product Type & Application
2.7 Apomorphine Delivery Device Market Competitive Situation and Trends
2.7.1 Apomorphine Delivery Device Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Apomorphine Delivery Device Players Market Share by Revenue
2.7.3 Global Apomorphine Delivery Device Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Apomorphine Delivery Device Retrospective Market Scenario by Region
3.1 Global Apomorphine Delivery Device Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Apomorphine Delivery Device Global Apomorphine Delivery Device Sales by Region: 2019-2030
3.2.1 Global Apomorphine Delivery Device Sales by Region: 2019-2024
3.2.2 Global Apomorphine Delivery Device Sales by Region: 2025-2030
3.3 Global Apomorphine Delivery Device Global Apomorphine Delivery Device Revenue by Region: 2019-2030
3.3.1 Global Apomorphine Delivery Device Revenue by Region: 2019-2024
3.3.2 Global Apomorphine Delivery Device Revenue by Region: 2025-2030
3.4 North America Apomorphine Delivery Device Market Facts & Figures by Country
3.4.1 North America Apomorphine Delivery Device Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Apomorphine Delivery Device Sales by Country (2019-2030)
3.4.3 North America Apomorphine Delivery Device Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Apomorphine Delivery Device Market Facts & Figures by Country
3.5.1 Europe Apomorphine Delivery Device Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Apomorphine Delivery Device Sales by Country (2019-2030)
3.5.3 Europe Apomorphine Delivery Device Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Apomorphine Delivery Device Market Facts & Figures by Country
3.6.1 Asia Pacific Apomorphine Delivery Device Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Apomorphine Delivery Device Sales by Country (2019-2030)
3.6.3 Asia Pacific Apomorphine Delivery Device Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Apomorphine Delivery Device Market Facts & Figures by Country
3.7.1 Latin America Apomorphine Delivery Device Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Apomorphine Delivery Device Sales by Country (2019-2030)
3.7.3 Latin America Apomorphine Delivery Device Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Apomorphine Delivery Device Market Facts & Figures by Country
3.8.1 Middle East and Africa Apomorphine Delivery Device Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Apomorphine Delivery Device Sales by Country (2019-2030)
3.8.3 Middle East and Africa Apomorphine Delivery Device Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Apomorphine Delivery Device Sales by Type (2019-2030)
4.1.1 Global Apomorphine Delivery Device Sales by Type (2019-2024)
4.1.2 Global Apomorphine Delivery Device Sales by Type (2025-2030)
4.1.3 Global Apomorphine Delivery Device Sales Market Share by Type (2019-2030)
4.2 Global Apomorphine Delivery Device Revenue by Type (2019-2030)
4.2.1 Global Apomorphine Delivery Device Revenue by Type (2019-2024)
4.2.2 Global Apomorphine Delivery Device Revenue by Type (2025-2030)
4.2.3 Global Apomorphine Delivery Device Revenue Market Share by Type (2019-2030)
4.3 Global Apomorphine Delivery Device Price by Type (2019-2030)
5 Segment by Application
5.1 Global Apomorphine Delivery Device Sales by Application (2019-2030)
5.1.1 Global Apomorphine Delivery Device Sales by Application (2019-2024)
5.1.2 Global Apomorphine Delivery Device Sales by Application (2025-2030)
5.1.3 Global Apomorphine Delivery Device Sales Market Share by Application (2019-2030)
5.2 Global Apomorphine Delivery Device Revenue by Application (2019-2030)
5.2.1 Global Apomorphine Delivery Device Revenue by Application (2019-2024)
5.2.2 Global Apomorphine Delivery Device Revenue by Application (2025-2030)
5.2.3 Global Apomorphine Delivery Device Revenue Market Share by Application (2019-2030)
5.3 Global Apomorphine Delivery Device Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Supernus Pharmaceuticals
6.1.1 Supernus Pharmaceuticals Corporation Information
6.1.2 Supernus Pharmaceuticals Description and Business Overview
6.1.3 Supernus Pharmaceuticals Apomorphine Delivery Device Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Supernus Pharmaceuticals Apomorphine Delivery Device Product Portfolio
6.1.5 Supernus Pharmaceuticals Recent Developments/Updates
6.2 Britannia Pharmaceuticals STADA
6.2.1 Britannia Pharmaceuticals STADA Corporation Information
6.2.2 Britannia Pharmaceuticals STADA Description and Business Overview
6.2.3 Britannia Pharmaceuticals STADA Apomorphine Delivery Device Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Britannia Pharmaceuticals STADA Apomorphine Delivery Device Product Portfolio
6.2.5 Britannia Pharmaceuticals STADA Recent Developments/Updates
6.3 Ever Pharma
6.3.1 Ever Pharma Corporation Information
6.3.2 Ever Pharma Description and Business Overview
6.3.3 Ever Pharma Apomorphine Delivery Device Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Ever Pharma Apomorphine Delivery Device Product Portfolio
6.3.5 Ever Pharma Recent Developments/Updates
6.4 Evolan Pharma AB (PharmSwed)
6.4.1 Evolan Pharma AB (PharmSwed) Corporation Information
6.4.2 Evolan Pharma AB (PharmSwed) Description and Business Overview
6.4.3 Evolan Pharma AB (PharmSwed) Apomorphine Delivery Device Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Evolan Pharma AB (PharmSwed) Apomorphine Delivery Device Product Portfolio
6.4.5 Evolan Pharma AB (PharmSwed) Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Apomorphine Delivery Device Industry Chain Analysis
7.2 Apomorphine Delivery Device Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Apomorphine Delivery Device Production Mode & Process
7.4 Apomorphine Delivery Device Sales and Marketing
7.4.1 Apomorphine Delivery Device Sales Channels
7.4.2 Apomorphine Delivery Device Distributors
7.5 Apomorphine Delivery Device Customers
8 Apomorphine Delivery Device Market Dynamics
8.1 Apomorphine Delivery Device Industry Trends
8.2 Apomorphine Delivery Device Market Drivers
8.3 Apomorphine Delivery Device Market Challenges
8.4 Apomorphine Delivery Device Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
